A study published in Oncotarget is highlighting a promising new approach to fighting pancreatic cancer. The paper, titled "The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation," was led by first author Kweku Ofosu-Asante and corresponding author Nazarius S. Lamango of the Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health in Tallahassee, Florida.
...

1 week ago
16








English (US) ·